Amplifyer Bio
Health Care · Molecular Diagnostics
$7.1Mlatest round · Venture round · Sep 2024 · 2 yr ago
1backers · Pillar VC
10+team · employees, estimated range
2023founded
Overview
A novel priming approach that increases circulating tumor DNA—improving detection and enabling better clinical decisions without changing workflows.
Key facts
These are the key facts about Amplifyer Bio on Alion as of Nov 13, 2026. Amplifyer Bio is headquartered in Lexington, United States. It was founded in 2023. The latest round is Venture - Series Unknown of $7.1M, announced in 2024.
- Headquarters
- Lexington, United StatesAlion company profile, updated Oct 13, 2026
- Founded
- 2023Alion company profile, updated Oct 13, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $7.1MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $7.1M · Sep 27, 2024SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$7.1M
1 round on record
Latest round
$7.1M
Venture round · Sep 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
Pillar VC
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2024 | $7.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Amplifyer Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Eric HuangExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Liquid biopsy for the early detection of gastric cancer. With only a blood sample, and even without symptoms, detects a tumor in the…
Valius Sciences is a diagnostics and bioinformatics company building comprehensive DNA, RNA and protein assessments of tumors for cancer…
Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma…
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…
Biomodal's duet platform reads genetics, methylation and fragmentomics from the same DNA molecule — integrated multiomic insight from a…
Hire expert genealogists or take genealogy courses to trace your family history. DNA analysis, brick wall solutions, and global research…
Financials
Total raised
$7.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $7.1M | Details |
People
Eric Huang
Executive Officer, Director
J. Love
Director
Thomas de Vlaam
Director
Viktor Adalsteinsson
Director
Stanley Lapidus
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Pillar VCVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Lexington
United States
HQ
10-50 est. staff
How to cite this page
Alion, "Amplifyer Bio: key facts", as of Nov 13, 2026. https://alion.io/company/amplifyer
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0